Pediatric Perspective on the EUCAST Definitions for S, I and R

Affiliations

¹ From the Department for Epidemiology, Institute for Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
² Department for Infectious Diseases and Vaccinology.
³ Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, Basel, Switzerland.

Malte Kohns Vasconcelos et al. Pediatr Infect Dis J. 2025.

. 2025 Apr 1;44(4):e120-e121.

doi: 10.1097/INF.0000000000004778. Epub 2025 Feb 21.

¹ From the Department for Epidemiology, Institute for Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
² Department for Infectious Diseases and Vaccinology.
³ Department of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, Basel, Switzerland.

No abstract available

References

1. European Committee on Antimicrobial Susceptibility Testing. Definitions of S, I and R 2019. Available from: https://www.eucast.org/newsiandr . Accessed January 6, 2025.
1. Clinical and Laboratory Standards Institute. Re-exploring the intermediate interpretive category 2021. Available from: https://clsi.org/about/blog/re-exploring-the-intermediate-interpretive-c... . Accessed January 6, 2025.
1. European Committee on Antimicrobial Susceptibility Testing. Dosages table 2025. Available from: https://www.eucast.org/clinical_breakpoints . Accessed January 6, 2025.
1. Aguilera-Alonso D, Cantón R, Giske CG, et al. Searching high and low: call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing survey on dosage of antibacterial agents in children-part one. Pediatr Infect Dis J. 2022;41:e182–e185.
1. Wilson J, Elgohari S, Livermore DM, et al. Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clin Microbiol Infect. 2011;17:451–458.